[Federal Register Volume 79, Number 74 (Thursday, April 17, 2014)]
[Notices]
[Pages 21782-21784]
[FR Doc No: 2014-08256]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

[Docket Number USCG-2009-0139; OMB Control Number: 1625-0043]

Information Collection Request to Office of Management and Budget

AGENCY: Coast Guard, DHS.

ACTION: Sixty-day notice requesting comments.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
Coast Guard plans to submit an Information Collection Request (ICR) to
the Office of Management and Budget (OMB), Office of Information and
Regulatory Affairs (OIRA), requesting a revision to the following
collection of information: 1625-0043, Ports and Waterways Safety Act--
Title 33, Subchapter P. The Coast Guard invites comments as described
below.

DATES: Comments must reach the Coast Guard on or before June 16, 2014.

ADDRESSES: You may submit comments identified by Coast Guard docket
number [USCG-2009-0139] to the Docket Management Facility (DMF) at the
U.S. Department of Transportation (DOT). To avoid duplicate
submissions, please use only one of the following means:
    (1) Online: http://www.regulations.gov.
    (2) Mail: DMF (M-30), DOT, West Building Ground Floor, Room W12-
140, 1200 New Jersey Avenue SE., Washington, DC 20590-0001.
    (3) Hand delivery: Same as mail address above, between 9 a.m. and 5
p.m., Monday through Friday, except Federal holidays. The telephone
number is<PHONE_NUMBER>.
    (4) Fax:<PHONE_NUMBER>. To ensure your comments are received in a
timely manner, mark the fax, to attention Desk Officer for the Coast
Guard.
    The DMF maintains the public docket for this Notice. Comments and
material received from the public, as well as

documents mentioned in this Notice as being available in the docket,
will become part of the docket and will be available for inspection or
copying at room W12-140 on the West Building Ground Floor, 1200 New
Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays. You may also find the docket
on the Internet at http://www.regulations.gov.
    A copy of this ICR is available within this notice and through the
docket on the Internet at http://www.regulations.gov. Additionally,
copies are available from: COMMANDANT (CG-612), ATTN PAPERWORK
REDUCTION ACT MANAGER, US COAST GUARD, 2703 MARTIN LUTHER KING JR AVE
SE STOP 7710, WASHINGTON DC 20593-7710.

FOR FURTHER INFORMATION CONTACT: Contact Mr. Anthony Smith, Office of
Information Management, telephone<PHONE_NUMBER>, or fax<PHONE_NUMBER>,
for questions on these documents. Contact Ms. Cheryl Collins, Program
Manager, Docket Operations,<PHONE_NUMBER>, for questions on the docket.

SUPPLEMENTARY INFORMATION:

Public Participation and Request for Comments

    This Notice relies on the authority of the Paperwork Reduction Act
of 1995; 44 U.S.C. Chapter 35, as amended. An ICR is an application to
OIRA seeking the approval, extension, or renewal of a Coast Guard
collection of information (Collection). The ICR contains information
describing the Collection's purpose, the Collection's likely burden on
the affected public, an explanation of the necessity of the Collection,
and other important information describing the Collection.
    The Coast Guard invites comments on whether this ICR should be
granted based on the Collection being necessary for the proper
performance of Departmental functions. In particular, the Coast Guard
would appreciate comments addressing: (1) The practical utility of the
Collection; (2) The accuracy of the estimated burden of the Collection;
(3) Ways to enhance the quality, utility, and clarity of information
subject to the Collection; and (4) Ways to minimize the burden of the
Collections on respondents, including the use of automated collection
techniques or other forms of information technology.
    We will consider all comments and material received during the
comment period. This notice requesting comments and the ICR are related
to and referenced in the final rule for the Regulated Navigation Area
(RNA); Gulf Intracoastal Waterway (GIWW), Inner Harbor Navigation Canal
(IHNC), New Orleans, LA. The information collected allows the Coast
Guard to ensure that pre-planned deviations from the RNA, as afforded
by the regulation, are done so safely and securely. The Coast Guard
published the final rulemaking to enable vessels, facility owners and
operators sufficient time to prepare and if desired, pre-plan safe and
secure deviation from RNA requirements in time for the 2014 Hurricane
Season.
    We encourage you to respond to this request by submitting comments
and related materials. Comments must contain the OMB Control Number of
the ICR, [OMB control no. 1625-0043], and the docket number of this
request, [USCG-2009-0139], and must be received by June 16, 2014. We
will post all comments received, without change, to http://www.regulations.gov. They will include any personal information you
provide. We have an agreement with DOT to use their DMF. Please see the
``Privacy Act'' paragraph below.

Submitting Comments

    If you submit a comment, please include the docket number, [USCG-
2009-0139], indicate the specific section of the document to which each
comment applies, providing a reason for each comment. You may submit
your comments and material online (via http://www.regulations.gov), by
fax, mail, or hand delivery, but please use only one of these means. If
you submit a comment online via www.regulations.gov, it will be
considered received by the Coast Guard when you successfully transmit
the comment. If you fax, hand deliver, or mail your comment, it will be
considered as having been received by the Coast Guard when it is
received at the DMF. We recommend you include your name, mailing
address, an email address, or other contact information in the body of
your document so that we can contact you if we have questions regarding
your submission. Please note that all comments will be posted to the
online docket without change and that any personal information you
include can be searchable online. Please see the ``Privacy Act''
paragraph below (see also the Federal Register Privacy Act notice
regarding our public dockets, 73 FR 3316, Jan. 17, 2008).
    You may submit your comments and material by electronic means,
mail, fax, or delivery to the DMF as indicated under ADDRESSES; but
please submit them by only one means. To submit your comment online, go
to http://www.regulations.gov, and type ``USCG-2014-0094'' in the
``Search'' box. If you submit your comments by mail or hand delivery,
submit them in an unbound format, no larger than 8\1/2\ by 11 inches,
suitable for copying and electronic filing. If you submit comments by
mail and would like to know that they reached the Facility, please
enclose a stamped, self-addressed postcard or envelope. We will
consider all comments and material received during the comment period
and will address them accordingly.

Viewing Comments and Documents

    To view comments, as well as documents mentioned in this Notice as
being available in the docket, go to http://www.regulations.gov, click
on the ``read comments'' box, which will then become highlighted in
blue. In the ``Search'' box insert ``USCG-2009-0139'' and click
``Search.'' Click the ``Open Docket Folder'' in the ``Actions'' column.
You may also visit the DMF in Room W12-140 on the ground floor of the
DOT West Building, 1200 New Jersey Avenue SE., Washington, DC 20590,
between 9 a.m. and 5 p.m., Monday through Friday, except Federal
holidays.

Privacy Act

    Anyone can search the electronic form of comments received in
dockets by the name of the individual submitting the comment (or
signing the comment, if submitted on behalf of an association,
business, labor union, etc.). You may review a Privacy Act statement
regarding Coast Guard public dockets in the January 17, 2008, issue of
the Federal Register (73 FR 3316).

Information Collection Request

    Title: Approval of Pre-planned Deviation from the Regulated
Navigation Area (RNA); Gulf Intracoastal Waterway (GIWW), Inner Harbor
Navigation Canal (IHNC), New Orleans, LA. The final rule for this RNA
published on April 17, 2014 at 79 FR [INSERT FR PAGE NUMBER FOR FINAL
RULE] under the same docket number, USCG-2009-0139.
    OMB Control Number: 1625-0043.

SUMMARY: The Hurricane Operations Plans submitted to the Coast Guard
provides information supporting the choice to deviate from RNA
restrictions and remain within certain RNA areas during enforcement.
These plans will include: Total number of remaining vessels and
description, name, IMO number, etc. of each vessel; diagram of the
facility; mooring arrangement details and certification; contact
information for POC at facility; and insurance

disclosures. Storm Specific Verification Reports as detailed under the
established Sector New Orleans Maritime Hurricane Contingency Port Plan
at http://homeport.uscg.mil/nola will also be collected.
    Need: Approval of the Hurricane Operations Plans by the Coast Guard
ensures that facilities and vessels that choose to deviate from the RNA
restrictions during enforcement and remain within certain areas of the
RNA are able to do so safely and securely without presenting a threat
to the flood protection system and possibly causing a breech leading to
flooding in the Greater New Orleans area.
    Use: The Coast Guard will evaluate the information to confirm that
the facilities and vessels have a plan in place that meets requirements
to remain safely and securely within the RNA.
    Description of the Respondents: Waterfront facility and vessel
owners and operators operating within the RNA.
    Number of Respondents: 15.
    Frequency of Response: Once in full and then annually to provide
updated information based on changes in facility and vessel operations.
    Burden of Response: Under 5 CFR 1320.3(b)(2), the time, effort, and
financial resources necessary to comply with the information required
to deviate under this rule is excluded because it will be incurred in
the normal course of business and activities. The vessel information,
recordkeeping, insurance disclosure, mooring plans and certifications,
and emergency contact information required to deviate from the RNA are
not only usual and customary, but commonly required under self-imposed
operating plans, insurance requirements, or facility requirements.
Therefore, the information required is already maintained by the
facilities and vessels as part of their day-to-day operations.
Additionally, the Coast Guard received no comments indicating that this
information presents a burden to the facilities and vessels and expects
to receive no adverse comment to revising the existing OMB control no.
1625-0043 to include this rule.
    Estimate of Total Annual Burden: The estimated burden involved in
providing the information required for deviation is 180 hours (12 hours
per responding facility/vessel owner). However, under 5 CFR
1320.3(b)(2), the time, effort, and financial resources necessary to
comply with the information required to deviate under this rule is
excluded because it will be incurred in the normal course of business
and activities. Therefore, the estimated burden for OMB control number
1625-0043 is expected to remain unchanged.

    Authority: The Paperwork Reduction Act of 1995; 44 U.S.C.
Chapter 35, as amended.

    Dated: April 1, 2014.
K. S. Cook,
Rear Admiral, U.S. Coast Guard, Commander, Eighth Coast Guard District.
[FR Doc. 2014-08256 Filed 4-16-14; 8:45 am]
BILLING CODE 9110-04-P


[Federal Register Volume 88, Number 77 (Friday, April 21, 2023)]
[Notices]
[Page 24616]
[FR Doc No: 2023-08445]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2023-0100; FRL-10740-01-OCSPP]

Pesticide Program Dialogue Committee; Notice of Public Meeting

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the Federal Advisory Committee Act (FACA), the
Environmental Protection Agency's (EPA's) Office of Pesticide Programs
is announcing a virtual public meeting of the Pesticide Program
Dialogue Committee (PPDC) on May 31 and June 1, 2023, with
participation by webcast only. There will be no in-person gathering for
this meeting.

DATES: Virtual meeting: May 31, 2023, and June 1, 2023. On or before
May 23, 2023, you must register to attend the virtual meeting and
request special accommodations, as well as request an opportunity to
present oral comments at the virtual meeting.

ADDRESSES:
    Virtual meeting: You must register to receive the webcast meeting
link for this virtual meeting by following the instructions on the EPA
website at https://www.epa.gov/pesticide-advisory-committees-and-regulatory-partners/pesticide-program-dialogue-committee-ppdc.
    Special accommodations: For information on access or services for
individuals with disabilities, and to request accommodation for a
disability, please contact the person listed under FOR FURTHER
INFORMATION CONTACT. To allow EPA time to process the request for
special accommodations, requests should be submitted on or before May
23, 2023.

FOR FURTHER INFORMATION CONTACT: Michelle Arling, Office of Pesticide
Programs (7501M), Environmental Protection Agency, 1200 Pennsylvania
Ave. NW (7101M), Washington, DC 20460; telephone number: (202) 566-
1260; email address: [email protected].

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    You may be potentially affected by this action if you work in in
agricultural settings or if you are concerned about implementation of
the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) (7
U.S.C. 136 et seq.); the Federal Food, Drug, and Cosmetic Act (FFDCA)
(21 U.S.C. 301 et seq.); the Pesticide Registration Improvement Act
(PRIA) (which amends FIFRA section 33); and the Endangered Species Act
(ESA) (16 U.S.C. 1531 et seq.). Potentially affected entities may
include but are not limited to: Agricultural workers and farmers;
pesticide industry and trade associations; environmental, consumer, and
farm worker groups; pesticide users and growers; animal rights groups;
pest consultants; state, local, and tribal governments; academia;
public health organizations; and the public. If you have questions
regarding the applicability of this action to a particular entity,
consult the person listed under FOR FURTHER INFORMATION CONTACT.

B. How can I get copies of this document and other related information?

    The docket for this action, identified under docket identification
(ID) number EPA-HQ-OPP-2023-0100, is available online at https://www.regulations.gov. Additional instructions on visiting the docket,
along with more information about dockets generally, is available at
https://www.epa.gov/dockets.

II. Background

    The PPDC is a federal advisory committee chartered under the
Federal Advisory Committee Act (FACA), Public Law 92-463. EPA
established the PPDC in September 1995 to provide policy advice,
information and recommendations to the EPA Administrator through the
Director of the Office of Pesticide Programs, Office of Chemical Safety
and Pollution Prevention. The PPDC provides a public forum to discuss a
wide variety of pesticide regulatory developments and reform
initiatives, evolving public policy and program implementation issues
associated with evaluating and reducing risks from the use of
pesticides.

III. How do I participate in the virtual public meeting?

A. Virtual Meeting

    The virtual meeting will be conducted via webcast. Please visit
https://www.epa.gov/pesticide-advisory-committees-and-regulatory-partners/pesticide-program-dialogue-committee-ppdc to find a link to
register for the meeting. Instructions for joining the meeting will be
sent via email to those that register for the meeting.

B. Oral Comments

    Requests to make brief oral comments to the PPDC during the virtual
meeting should be submitted to the individual listed under FOR FURTHER
INFORMATION CONTACT on or before noon on the date set in the DATES
section.
    Authority: 5 U.S.C. appendix 2 et seq. and 7 U.S.C. 136 et seq.

    Dated: April 17, 2023.
Edward Messina,
Director, Office of Pesticide Programs.
[FR Doc. 2023-08445 Filed 4-20-23; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 78, Number 88 (Tuesday, May 7, 2013)]
[Notices]
[Page 26636]
[FR Doc No: 2013-10732]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings

    Take notice that the Commission has received the following Natural
Gas Pipeline Rate and Refund Report filings:

Filings Instituting Proceedings

    Docket Numbers: RP13-822-000.
    Applicants: Elba Express Company, L.L.C.
    Description: Annual Fuel Tracker Filing of Elba Express Company,
L.L.C.
    Filed Date: 4/29/13.
    Accession Number: 20130429-5050.
    Comments Due: 5 p.m. ET 5/13/13.

    Docket Numbers: RP13-823-000.
    Applicants: CenterPoint Energy--Mississippi River T.
    Description: Negotiated Rate Filing Effective May 1, 2013 to be
effective 5/1/2013.
    Filed Date: 4/29/13.
    Accession Number: 20130429-5099.
    Comments Due: 5 p.m. ET 5/13/13.

    Docket Numbers: RP13-824-000.
    Applicants: ANR Pipeline Company.
    Description: ANR Pipeline Company Operational Purchases and Sales
Report for 12 Months Ending December 31, 2012.
    Filed Date: 4/29/13.
    Accession Number: 20130429-5107.
    Comments Due: 5 p.m. ET 5/13/13.

    Docket Numbers: RP13-825-000.
    Applicants: Gulf Crossing Pipeline Company LLC.
    Description: Amendments to Neg Rate Agmts (Vanguard 597-7 and 598-
8) to be effective 5/1/2013.
    Filed Date: 4/29/13.
    Accession Number: 20130429-5111.
    Comments Due: 5 p.m. ET 5/13/13.

    Docket Numbers: RP13-826-000.
    Applicants: Gulf Crossing Pipeline Company LLC.
    Description: Amendment to Neg Rate Agmt--JP Morgan 156-5 to be
effective 5/1/2013.
    Filed Date: 4/29/13.
    Accession Number: 20130429-5112.
    Comments Due: 5 p.m. ET 5/13/13.

    Docket Numbers: RP13-827-000.
    Applicants: Petal Gas Storage, L.L.C.
    Description: Non-conforming Service Agmt--PSEG to be effective 5/1/
2013.
    Filed Date: 4/29/13.
    Accession Number: 20130429-5116.
    Comments Due: 5 p.m. ET 5/13/13.

    Docket Numbers: RP13-828-000.
    Applicants: Gulf South Pipeline Company, LP.
    Description: Amendment to Neg Rate Agmt--QEP 37657-29 to be
effective 5/1/2013.
    Filed Date: 4/29/13.
    Accession Number: 20130429-5122.
    Comments Due: 5 p.m. ET 5/13/13.

    Docket Numbers: RP13-829-000.
    Applicants: Gulf South Pipeline Company, LP.
    Description: Cap Rel Neg Rate Agmt--Willmut 35221 to BP Energy
40900 to be effective 5/1/2013.
    Filed Date: 4/29/13.
    Accession Number: 20130429-5131.
    Comments Due: 5 p.m. ET 5/13/13.

    Docket Numbers: RP13-830-000.
    Applicants: Gulf South Pipeline Company, LP.
    Description: Cap Rel Neg Rate Agmt (QEP 37657 to Texla 40899) to be
effective 5/1/2013.
    Filed Date: 4/29/13.
    Accession Number: 20130429-5135.
    Comments Due: 5 p.m. ET 5/13/13.

    Docket Numbers: RP13-831-000.
    Applicants: ANR Storage Company.
    Description: ANR Storage Company Operational Purchases and Sales of
Gas Report for 12 Months Ending December 31, 2013.
    Filed Date: 4/29/13.
    Accession Number: 20130429-5181.
    Comments Due: 5 p.m. ET 5/13/13.

    Docket Numbers: RP13-832-000.
    Applicants: Bison Pipeline LLC.
    Description: Bison Pipeline LLC Operational Purchases and Sales
Report for 12 Months Ending December 31, 2012.
    Filed Date: 4/29/13.
    Accession Number: 20130429-5185.
    Comments Due: 5 p.m. ET 5/13/13.

    Docket Numbers: RP13-833-000.
    Applicants: Great Lakes Gas Transmission Limited Par.
    Description: Great Lakes Gas Transmission Limited Partnership
Operational Purchases and Sales of Gas Report for 12 Months Ending
December 31, 2012.
    Filed Date: 4/29/13.
    Accession Number: 20130429-5189.
    Comments Due: 5 p.m. ET 5/13/13.

    Docket Numbers: RP13-834-000.
    Applicants: Northern Border Pipeline Company.
    Description: Northern Border Pipeline Company Operational Purchases
and Sales of Gas Report for 12 Months Ending December 31, 2012.
    Filed Date: 4/29/13.
    Accession Number: 20130429-5191.
    Comments Due: 5 p.m. ET 5/13/13.

    Docket Numbers: RP13-835-000.
    Applicants: Blue Lake Gas Storage Company.
    Description: Blue Lake Gas Storage Company Operational Purchases
and Sales of Gas Report for 12 Months Ending December 31, 2012.
    Filed Date: 4/29/13.
    Accession Number: 20130429-5309.
    Comments Due: 5 p.m. ET 5/13/13.

    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, and service can be found at:
http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other
information, call<PHONE_NUMBER> (toll free). For TTY, call (202) 502-
8659.

    Dated April 30, 2013.
Nathaniel J. Davis, Sr.,
Deputy Secretary
[FR Doc. 2013-10732 Filed 5-6-13; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 76, Number 156 (Friday, August 12, 2011)]
[Notices]
[Pages 50231-50233]
[FR Doc No: 2011-20574]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-D-0530]

Mobile Medical Applications Draft Guidance; Public Workshop

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public workshop; request for comments.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing a public
workshop entitled: ``Mobile Medical Applications Draft Guidance.'' The
purpose of the workshop is to provide a forum for discussion with FDA
and to encourage public comment on the following topics: FDA's recently
issued draft guidance document entitled ``Mobile Medical
Applications,'' how FDA should approach accessories and particularly
mobile medical applications that are accessories to other medical
devices, and standalone software that provides clinical decision
support.
    Date and Time: The public workshop will be held on September 12 and
13, 2011. Submit electronic and written comments by October 19, 2011.
    Location: The public workshop will be held at the FDA White Oak
Campus, 10903 New Hampshire Ave., Building 31 Conference Center, the
Great Room (rm. 1503), Silver Spring, MD 20993-0002.
    Contact Person: Bakul Patel, Center for Devices and Radiological
Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg.
66, rm. 5456, Silver Spring, MD 20993,<PHONE_NUMBER>,
<EMAIL_ADDRESS>    Registration and Requests for Oral Presentations: Registration is
free and will be on a first-come, first-served basis. Persons
interested in attending this workshop must register online by 5 p.m. on
September 9, 2011. For those without Internet access, please call the
contact person to register.
    Early registration is recommended because seating is limited and,
therefore, FDA may limit the number of participants from each
organization. If time and space permit, onsite registration on the day
of the public workshop will be provided beginning at 7:30 a.m. Non-U.S.
citizens are subject to additional security screening, and they should
register as soon as possible.
    If you need special accommodations due to a disability, please
contact Susan Monahan (e-mail<EMAIL_ADDRESS>or phone: 301-
796-5661) no later than September 9, 2011.
    This workshop will also be provided via webcast. Persons interested
in participating by webcast must register online by 5 p.m. on September
9, 2011. Early registration is recommended because webcast connections
are limited. Organizations are requested to register all participants,
but view using one connection per location. Webcast participants will
be sent connection

requirements. To register for the public workshop--whether attending in
person or for the webcast--please visit http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/default.htm (or go to
the FDA Medical Devices News & Events--Workshops & Conferences calendar
and select this public workshop from the posted events list). Please
provide complete contact information for each attendee, including name,
title, affiliation, address, e-mail, telephone, and FAX number.
Registrants will receive confirmation once they have been accepted. You
will be notified if you are on a waitlist.
    This workshop includes a public comment session. During online
registration you may indicate if you wish to make an oral presentation
during a public comment session at the public workshop, and which topic
you wish to address in your presentation. FDA has included topics for
comment in this document. FDA will do its best to accommodate requests
to speak. Individuals and organizations with common interests are urged
to consolidate or coordinate their presentations, and request time for
a joint presentation. FDA will determine the amount of time allotted to
each presenter and the approximate time each oral presentation is to
begin. All requests to make oral presentations, as well as presentation
materials, must be sent to the contact person by September 9, 2011.
    Comments: Regardless of attendance at the public workshop,
interested persons may submit either electronic or written comments
until October 19, 2011. Submit electronic comments to http://www.regulations.gov. Submit written comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
rm. 1061, Rockville, MD 20852. It is only necessary to send one set of
comments. It is no longer necessary to send two copies of mailed
comments. Identify comments with the docket number found in brackets in
the heading of this document. Received comments may be seen in the
Division of Dockets Management between 9 a.m. and 4 p.m., Monday
through Friday.

SUPPLEMENTARY INFORMATION:

I. What is the background and purpose for holding this public workshop?

    The purpose of the workshop is to provide a forum for discussion
with FDA and to encourage public comment from interested stakeholders
on the following issues previously raised in the notice of availability
for the draft guidance (76 FR 43689, July 21, 2011): FDA's recently-
issued draft guidance document entitled ``Mobile Medical
Applications,'' how FDA should approach accessories and particularly
mobile medical applications that are accessories to other medical
devices, and stand-alone software that provides clinical decision
support.
    Given the rapid expansion and broad applicability of mobile
applications (mobile apps), FDA issued the draft guidance, ``Mobile
Medical Applications'' on July 21, 2011, to clarify the types of mobile
apps to which the FDA intends to apply its authority (http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm263280.htm).
    At this time, FDA intends to apply its regulatory requirements to a
subset of mobile apps that the Agency is calling mobile medical
applications (mobile medical apps). For purposes of the draft guidance
and the public workshop discussion, a ``mobile medical app'' is a
mobile application that meets the definition of ``device'' in section
201(h) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21
U.S.C. 321(h)) \1\; and either:
---------------------------------------------------------------------------

    \1\ Products that are built with or consist of computer and/or
software components or applications are subject to regulation as
devices when they meet the definition of a device in section 201(h)
of the FD&C Act. That provision defines a device as ``* * * an
instrument, apparatus, implement, machine, contrivance, implant, in
vitro reagent * * *'', that is ``* * * intended for use in the
diagnosis of disease or other conditions, or in the cure,
mitigation, treatment, or prevention of disease, in man * * * '' or
``* * * intended to affect the structure or any function of the body
of man or other animals * * *''.
---------------------------------------------------------------------------

     Is used as an accessory to a regulated medical device; or
     Transforms a mobile platform into a regulated medical
device.
    This narrowly-tailored approach focuses on a subset of mobile apps
that either have traditionally been considered medical devices or
affect the performance or functionality of a currently regulated
medical device.
    Although some mobile apps that do not meet the definition of a
mobile medical app may meet the FD&C Act's definition of a device, FDA
intends to exercise enforcement discretion \2\ towards those mobile
apps.
---------------------------------------------------------------------------

    \2\ This means that FDA intends to exercise its discretion to
decline to pursue enforcement actions for violations of the FD&C Act
and applicable regulations by a manufacturer of a mobile medical
app, as specified in the draft guidance, ``Mobile Medical
Applications.'' This does not constitute a change in the
requirements of the FD&C Act or any applicable regulations.
---------------------------------------------------------------------------

II. What are the specific issues for discussion and public comment at
the public workshop?

    We welcome comments on all aspects of the draft guidance as well as
the following specific issues:
    1. FDA generally considers extensions of medical devices as
accessories to those medical devices. Accessories have been typically
regulated under the same classification as the connected medical
device. However, we recognize potential limitations to this policy for
mobile medical apps. FDA seeks comment on how the Agency should
approach accessories and particularly mobile medical apps that are
accessories to other medical devices so safety and effectiveness can be
reasonably assured. For example, one possible approach could be the
following:
     An accessory that does not change the intended use of the
connected device, but aids in the use of the connected medical device
could be regulated as class I. For example, such an accessory would be
similar to an infusion pump stand, which is currently classified as a
class I device because it supports the intended use of an infusion pump
(class II medical device). A mobile medical app that simply supports
the intended use of a regulated medical device could be classified as
class I with design controls as part of the quality systems
requirements;
     An accessory that extends the intended use of the
connected medical device could be classified with the connected device.
For example, if a mobile medical app that performs more detailed
analysis than the connected medical device while maintaining the
original intended use, which is data analysis, could be classified in
the same classification as the connected medical device; and
     An accessory that creates a new intended use from that of
the connected device(s) could be classified according to the risk posed
to patient safety by the new intended use, for example, if the intended
use of a mobile medical app is to provide prognosis relating to a
certain disease or condition and the mobile medical app is connected to
a device that does not have that intended use, the mobile medical app
may have a different level of risk than the connected device, resulting
in a different classification to assure safety and effectiveness of the
mobile medical app.
    2. FDA has not addressed in its draft guidance, ``Mobile Medical
Applications,'' stand-alone software (mobile or traditional
workstation) that analyzes, processes, or interprets medical device
data (collected

electronically or through manual entry of the device data) for purposes
of automatically assessing patient specific data or for providing
support in making clinical decisions. FDA plans to address such stand-
alone software in a separate guidance. In order to provide a reasonable
assurance of the safety and effectiveness of such software, and to
ensure consistency between the draft guidance, ``Mobile Medical
Applications,'' and the planned guidance on stand-alone software that
provides clinical decision support (CDS), FDA is seeking comment on the
following issues:
     What factors should FDA consider in determining the risk
classification of different types of software that provide CDS
functionality? Please provide examples of how those factors would be
applied for such software that you believe should be in class I, class
II, and class III;
     How should the FDA assess stand-alone software that
provides CDS functionality, to assure reasonable safety and
effectiveness? For example, to what extent can FDA rely on a
manufacturer's demonstration that it has a robust quality system with
appropriate quality assurance and design controls? Under what
circumstances should the submission of clinical data be required?; and
     Are there specific controls that manufacturers should
implement that could change the risk classification or reduce the
premarket data requirements for particular types of stand-alone
software that provide CDS functionality?

III. Where can I find out more about this public workshop?

    Background information on the public workshop, registration
information, the agenda, information about lodging, transcripts, and
other relevant information will be posted, as it becomes available, on
the Internet at http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/default.htm.

IV. Will there be transcripts of the meeting?

    Please be advised that as soon as a transcript is available, it
will be accessible at http://www.regulations.gov. It may be viewed at
the Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. A
transcript will also be available in either hard copy or on CD-ROM,
after submission of a Freedom of Information request. Written requests
are to be sent to Division of Freedom of Information (HFI-35), Office
of Management Programs, Food and Drug Administration, 5600 Fishers
Lane, rm. 6-30, Rockville, MD 20857.

    Dated: August 9, 2011.
Nancy K. Stade,
Deputy Director for Policy, Center for Devices and Radiological Health.
[FR Doc. 2011-20574 Filed 8-11-11; 8:45 am]
BILLING CODE 4160-01-P


[Federal Register Volume 88, Number 212 (Friday, November 3, 2023)]
[Notices]
[Pages 75583-75584]
[FR Doc No: 2023-24262]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #2

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER24-218-000.
    Applicants: Calpine Bethlehem, LLC, Calpine Mid-Atlantic
Generation, LLC, Calpine Mid Merit, LLC, Calpine Mid-Merit II, LLC,
Calpine New Jersey Generation, LLC, Zion Energy LLC.
    Description: Calpine Reactive Suppliers One-Time Limited
Prospective Waiver Request of the 90-day prior notice requirement in
Schedule 2 to the PJM OATT, allowing Information Filing submissions
less than 90 days prior to transaction consummation.
    Filed Date: 10/19/23.
    Accession Number: 20231019-5197.
    Comment Date: 5 p.m. ET 11/9/23.

    Docket Numbers: ER24-219-000.
    Applicants: Pacific Gas and Electric Company.
    Description: Petition for Limited Waiver of Pacific Gas and
Electric Company.
    Filed Date: 10/24/23.
    Accession Number: 20231024-5160.
    Comment Date: 5 p.m. ET 11/14/23.

    Docket Numbers: ER24-221-000.
    Applicants: Southwest Power Pool, Inc.
    Description: Sec.  205(d) Rate Filing: 1883R13 Evergy Kansas
Central, Inc. NITSA NOA to be effective 10/1/2023.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5026.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-222-000.
    Applicants: Southwest Power Pool, Inc.
    Description: Sec.  205(d) Rate Filing: 1895R13 Evergy Kansas
Central, Inc. NITSA NOA to be effective 10/1/2023.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5035.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-223-000.
    Applicants: Southern California Edison Company.
    Description: Sec.  205(d) Rate Filing: SCE 2024 RSBAA Update to be
effective 1/1/2024.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5063.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-224-000.
    Applicants: Midcontinent Independent System Operator, Inc.
    Description: Sec.  205(d) Rate Filing: 2023-10-27_MISO TOs
revisions to Attachment MM to be effective 1/1/2024.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5071.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-225-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Original ISA, Service
Agreement No. 7123; Queue No. AF2-192 to be effective 9/27/2023.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5083.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-226-000.
    Applicants: Evergy Missouri West, Inc., Evergy Metro, Inc.,
Southwest Power Pool, Inc.
    Description: Sec.  205(d) Rate Filing: Evergy Missouri West, Inc.
submits tariff filing per 35.13(a)(2)(iii: Revisions to Formula Rate
Template for the Evergy Companies to be effective 12/27/2023.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5090.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-227-000.
    Applicants: RPC Power, LLC.
    Description: Baseline eTariff Filing: Market-Based Rate Tariff
Application to be effective 10/28/2023.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5099.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-228-000.
    Applicants: South Cheyenne Solar, LLC.
    Description: Baseline eTariff Filing: Application for MBR Authority
and Initial Baseline Tariff Filing to be effective 12/1/2023.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5102.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-228-001.
    Applicants: South Cheyenne Solar, LLC.
    Description: Tariff Amendment: Amendment to Application for MBR
Authority and Initial Baseline Tariff Filing to be effective 12/1/2023.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5112.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-229-000
    Applicants: Alabama Power Company, Georgia Power Company,
Mississippi Power Company.
    Description: Sec.  205(d) Rate Filing: Alabama Power Company
submits tariff filing per 35.13(a)(2)(iii): Amendment of Americus Solar
(Americus Solar II) LGIA to be effective 10/13/2023.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5103.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-230-000.
    Applicants: New England Power and Light LLC.
    Description: Baseline eTariff Filing: Market-Based Rate Tariff
Application to be effective 10/28/2023.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5118.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-231-000.
    Applicants: West Penn Power Company, PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: West Penn Power Company
submits tariff filing per 35.13(a)(2)(iii): West Penn Power submits
Revisions to OATT, Att. H-11A to be effective 10/30/2023.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5120.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-232-000.
    Applicants: New York Transco, LLC, New York Independent System
Operator, Inc.
    Description: Sec.  205(d) Rate Filing: New York Transco, LLC
submits tariff filing per 35.13(a)(2)(iii): NY Transco 205: Proposed
Revisions re: Propel NY Cost Allocation and Containment to be effective
12/26/2023.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5125.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-233-000.
    Applicants: Progressive Light & Power LLC.
    Description: Baseline eTariff Filing: Market-Based Rate Tariff
Application to be effective 10/28/2023.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5128.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-234-000.
    Applicants: Black Hills Colorado Electric, LLC.
    Description: Tariff Amendment: Notice of Cancellation of Rate
Schedule No. 9 to be effective 1/1/2024.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5130.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-235-000
    Applicants: Metropolitan Edison Company, PJM Interconnection,
L.L.C.
    Description: Sec.  205(d) Rate Filing: Metropolitan Edison Company
submits

tariff filing per 35.13(a)(2)(iii): Met-Ed Amends 10 ECSAs (5435 6048
6150 6292 6297 6300 6301 6302 6336 6351) to be effective 12/31/9998.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5136.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-236-000.
    Applicants: Midcontinent Independent System Operator, Inc.
    Description: Sec.  205(d) Rate Filing: 2023-10-27_Att X NERC
Facility Interconnection Studies to be effective 1/1/2024.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5139
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-237-000.
    Applicants: Josco Energy Corp.
    Description: Tariff Amendment: Notice of Cancellation of MBR Tariff
to be effective 10/28/2023.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5163.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-238-000.
    Applicants: Josco Energy USA, LLC.
    Description: Tariff Amendment: Notice of Cancellation for MBR
Tariff to be effective 10/28/2023.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5166.
    Comment Date: 5 p.m. ET 11/17/23.

    Docket Numbers: ER24-239-000.
    Applicants: Tyr Energy, LLC.
    Description: Compliance filing: Tyr Energy Seller Category Status
Change to be effective 12/27/2023.
    Filed Date: 10/27/23.
    Accession Number: 20231027-5220.
    Comment Date: 5 p.m. ET 11/17/23.

    Take notice that the Commission received the following electric
securities filings:

    Docket Numbers: ES24-10-000.
    Applicants: NorthWestern Corporation.
    Description: Application Under Section 204 of the Federal Power Act
for Authorization to Issue Securities of NorthWestern Corporation.
    Filed Date: 10/25/23.
    Accession Number: 20231025-5290.
    Comment Date: 5 p.m. ET 11/15/23.

    The filings are accessible in the Commission's eLibrary system
(https://elibrary.ferc.gov/idmws/search/fercgensearch.asp) by querying
the docket number.
    Any person desiring to intervene, to protest, or to answer a
complaint in any of the above proceedings must file in accordance with
Rules 211, 214, or 206 of the Commission's Regulations (18 CFR 385.211,
385.214, or 385.206) on or before 5:00 p.m. Eastern time on the
specified comment date. Protests may be considered, but intervention is
necessary to become a party to the proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at:http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.
    The Commission's Office of Public Participation (OPP) supports
meaningful public engagement and participation in Commission
proceedings. OPP can help members of the public, including landowners,
environmental justice communities, Tribal members and others, access
publicly available information and navigate Commission processes. For
public inquiries and assistance with making filings such as
interventions, comments, or requests for rehearing, the public is
encouraged to contact OPP at<PHONE_NUMBER> or [email protected].

    Dated: October 27, 2023.
Debbie-Anne A. Reese,
Deputy Secretary.
[FR Doc. 2023-24262 Filed 11-2-23; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register: October 4, 2007 (Volume 72, Number 192)]
[Notices]
[Page 56826-56827]
[DOCID:fr04oc07-123]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

National Highway Traffic Safety Administration

[Docket No. NHTSA-2007-28735; Notice 1]

Mazda North American Operations, Receipt of Petition for Decision
of Inconsequential Noncompliance

    Mazda North American Operations (Mazda) has determined that certain
motor vehicle replacement equipment that it delivered prior to June 25,
2007 did not comply with paragraphs S4.1(k) and S4.1(l) of 49 CFR
571.209, Federal Motor Vehicle Safety Standard (FMVSS) No. 209, Seat
Belt Assemblies. MAZDA has filed an appropriate report pursuant to 49
CFR part 573, Defect and Noncompliance Responsibility and Reports.
    Pursuant to 49 U.S.C. 30118(d) and 30120(h), MAZDA has petitioned
for an exemption from the notification and remedy requirements of 49
U.S.C. Chapter 301 on the basis that this noncompliance is
inconsequential to motor vehicle safety.
    This notice of receipt of MAZDA's petition is published under 49
U.S.C. 30118 and 30120 and does not represent any agency decision or
other exercise of judgment concerning the merits of the petition.
    Affected are an unspecified quantity of seat belt replacement
assemblies delivered prior to June 25, 2007. Paragraphs S4.1(k) and
S4.1(l) of FMVSS No. 209 require:

    (k) Installation instructions. A seat belt assembly, other than
a seat belt assembly installed in a motor vehicle by an automobile
manufacturer, shall be accompanied by an instruction sheet providing
sufficient information for installing the assembly in a motor
vehicle. The installation instructions shall state whether the
assembly is for universal installation or for installation only in
specifically stated motor vehicles, and shall include at least those
items specified in SAE Recommended Practice J800c, ``Motor Vehicle
Seat Belt Installations,'' November 1973. If the assembly is for use
only in specifically stated motor vehicles, the assembly shall
either be permanently and legibly marked or labeled with the
following statement, or the instruction sheet shall include the
following statement:
    This seat belt assembly is for use only in [insert specific
seating position(s), e.g., ``front right''] in [insert specific
vehicle make(s) and model(s)].
    (l) Usage and maintenance instructions. A seat belt assembly or
retractor shall be accompanied by written instructions for the
proper use of the assembly, stressing particularly the importance of
wearing the assembly snugly and properly located on the body, and on
the maintenance of the assembly and periodic inspection of all
components. The instructions shall show the proper manner of
threading webbing in the hardware of seat belt assemblies in which
the webbing is not permanently fastened. Instructions for a
nonlocking retractor shall include a caution that the webbing must
be fully extended from the retractor during use of the seat belt
assembly unless the retractor is attached to the free end of webbing
which is not subjected to any tension during restraint of an
occupant by the assembly. Instructions for Type 2a shoulder belt
shall include a warning that the shoulder belt is not to be used
without a lap belt.

    MAZDA explains that three possible situations apply to the subject
seat belt replacement assemblies.
    In the first instance, the seat belt assembly instruction sheets
included with the replacement assemblies appropriate for Mazda B-series
pickup trucks and Mazda Navajo multipurpose passenger vehicles only
identified the assemblies as applicable to the Ford Ranger pickup
trucks or Ford Explorer multipurpose passenger vehicles, respectively.
Although other information provided was accurate for the Mazda
vehicles, the incorrect vehicle reference fails to comply with S4.1(k)
of the standard.
    Second, replacement seat belt assemblies produced for use in the

following vehicles did not include either the installation instructions
or the instructions for the proper use and maintenance of the
replacement seat belt assemblies. This fails to comply with both
paragraph S4.1(k) and paragraph S4.1(l) of the standard:

1992-1995 MY Mazda 929, delivered from 1991 to 2007
1990-2002 MY Mazda 626, delivered from 1989 to 2007
1994-1995 MY Mazda MX-3, delivered from 1993 to 2007
1994-2007 MY Mazda MX-5, delivered from 1993 to 2007
1988-1997 MY Mazda MX-6, delivered from 1987 to 2007
1993-1995 MY Mazda RX-7, delivered from 1992 to 2007
1999-2003 MY Mazda Protege, delivered from 1998 to 2007
2001-2008 MY Mazda Tribute, delivered from 2000 to 2007
2004-2007 MY Mazda Mazda6, delivered from 2003 to 2007
2006-2007 MY Mazda 5, delivered from 2005 to 2007
2007 MY Mazda CX-9, delivered from 2006 to 2007
2007 MY Mazda B-Series Truck, delivered from 2006 to 2007

    And finally, all remaining replacement seat belt assemblies
produced for use in the United States and its territories did not
include the instructions for the proper use and maintenance of the
replacement seat belt assemblies. This fails to comply with S4.1(l) of
the standard.
    MAZDA makes the argument that the MAZDA parts ordering system used
by Mazda dealers clearly identifies the correct service seat belt
components for any given model/model year seat position combination.
The parts are unique to each belt and are designed to assemble properly
only in their intended application. When ordering Mazda replacement
seat belt parts, the dealer must refer to the Mazda parts catalog to
identify the ordering part number with the information on the specific
vehicle model type, location and model year. Each replacement seat belt
assembly is packaged individually with a specific part number label to
ensure shipping the correct parts. Then, the dealer routinely checks to
confirm that the part received matches the one ordered. Given the
ordering system and process, the dealers could select, order, and
obtain the correct parts. Also, installation instructions for seat
belts are readily available in the Mazda workshop manuals and on the
Internet. Therefore, the seat belt parts can be successfully installed
with the information already available even though installation
instructions did not accompany the replacement seat belt assemblies.
    MAZDA further argues that since the instruction for proper use and
maintenance is described in the owner's manual which is installed in
the vehicle, incorrect usage and maintenance by the vehicle owner is
highly unlikely.
    MAZDA is not aware of any customer or field reports of service seat
belt assemblies being incorrectly installed in the subject applications
as a result of installation instructions not accompanying the service
part.
    MAZDA also stated that it is not aware of any reports requesting
installation instructions, which it believed to be related to the
noncompliances.
    Upon discovery of the subject noncompliance, MAZDA took action to
ensure that all replacement seat belt assemblies shipped in the future
are packaged with the required installation instructions. MAZDA has
also corrected all the replacement seat belt assemblies in the
inventory for shipment to dealers.
    In summation, MAZDA states that it has corrected the problem that
caused these errors so that they will not be repeated in future
production and that it believes that because the noncompliances are
inconsequential to motor vehicle safety that no corrective action is
warranted.
    Interested persons are invited to submit written data, views, and
arguments on this petition. Comments must refer to the docket and
notice number cited at the beginning of this notice and be submitted by
any of the following methods:
    a. By mail addressed to: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue, SE., Washington, DC 20590.
    b. By hand delivery to U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue, SE., Washington, DC 20590. The Docket Section is open on
weekdays from 10 am to 5 pm except Federal Holidays.
    c. Electronically: until September 29, 2007, by logging onto the
DOT Docket Management System Web site at http://dms.dot.gov; after

September 28, 2007, by logging onto the Federal Docket Management
System Web site at http://www.regulations.gov/. Follow the online

instructions for submitting comments. Comments may also be faxed to 1-
202-493-2251.
    The petition, supporting materials, and all comments received
before the close of business on the closing date indicated below will
be filed and will be considered. All comments and supporting materials
received after the closing date will also be filed and will be
considered to the extent possible. When the petition is granted or
denied, notice of the decision will be published in the Federal
Register pursuant to the authority indicated below.
    Comment closing date: November 5, 2007.

    Authority: 49 U.S.C. 30118, 30120: Delegations of authority at
CFR 1.50 and 501.8.

    Issued on: September 27, 2007.
Harry Thompson,
Acting Director, Office of Vehicle Safety Compliance.
 [FR Doc. E7-19604 Filed 10-3-07; 8:45 am]

BILLING CODE 4910-59-P


[Federal Register Volume 81, Number 16 (Tuesday, January 26, 2016)]
[Notices]
[Page 4346]
[FR Doc No: 2016-01541]

=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Sunshine Act Meeting

    Notice is hereby given, pursuant to the provisions of the
Government in the Sunshine Act, Public Law 94-409, that the Securities
and Exchange Commission will hold a Closed Meeting on Thursday, January
28, 2016 at 2:00 p.m.
    Commissioners, Counsel to the Commissioners, the Secretary to the
Commission, and recording secretaries will attend the Closed Meeting.
Certain staff members who have an interest in the matters also may be
present.
    The General Counsel of the Commission, or her designee, has
certified that, in her opinion, one or more of the exemptions set forth
in 5 U.S.C. 552b(c)(3), (5), (7), 9(B) and (10) and 17 CFR
200.402(a)(3), (5), (7), 9(ii) and (10), permit consideration of the
scheduled matter at the Closed Meeting.
    Commissioner Stein, as duty officer, voted to consider the items
listed for the Closed Meeting in closed session.
    The subject matter of the Closed Meeting will be:
    Institution and settlement of injunctive actions;
    Institution and settlement of administrative proceedings; and
    Other matters relating to enforcement proceedings.
    At times, changes in Commission priorities require alterations in
the scheduling of meeting items.
    For further information and to ascertain what, if any, matters have
been added, deleted or postponed, please contact the Office of the
Secretary at<PHONE_NUMBER>.

    Dated: January 21, 2016.
Brent J. Fields,
Secretary.
[FR Doc. 2016-01541 Filed 1-22-16; 11:15 am]
BILLING CODE 8011-01-P


From:        Robin Dunkins/RTP/USEPA/US

To:        Kelley Spence/RTP/USEPA/US@EPA

Cc:        John Bradfield/RTP/USEPA/US@EPA, Bill Schrock/RTP/USEPA/US@EPA

Date:        12/12/2011 12:27 PM

Subject:        OMB

________________________________________

Here are all the documents forwarded to OMB.

thanks

robin

Robin Dunkins

Leader, Natural Resources Group

Office of Air Quality Planning and Standards

US Environmental Protection Agency  (C504-03)

(phone)<PHONE_NUMBER>   (fax) 919-541- 3470

<EMAIL_ADDRESS>